seasonal influenza
Vaccines · 2015–2022
8decisions
6medicines
4carried consumer input
2individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| quadrivalent influenza vaccine (surface antigen, inactivated, cell-based) Prevention of influenza in Aboriginal and Torres Strait Islander people aged ≥5 to <65 years, people at increased risk of influenza disease complications aged… | Sep 2022 | Recommended with restriction | input received Lung Foundation Australia |
| inactivated quadrivalent influenza vaccine (split virion) Extension of listing for active immunisation of healthy children aged 6 months to <5 years for the prevention of seasonal influenza disease caused by influenza… | Jul 2020 | Recommended with restriction | input received Lung Foundation Australia |
| quadrivalent influenza vaccine Prevention of seasonal influenza in children aged 6 months to <5 years not currently eligible through the NIP, and in at-risk individuals currently eligible… | Jul 2019 | Recommended | 1 individuals Australian Immunisation Register · Immunisation Coalition · Immunisation Foundation |
| quadrivalent influenza vaccine (split virion, inactivated) Prevention of seasonal influenza in infants and young children aged 6 to 35 months of age who are at increased risk of severe influenza or are Aboriginal and… | Mar 2019 | Recommended with restriction | 1 individuals Pediatric Infectious Diseases Society |
| inactivated influenza vaccine (surface antigen), adjuvanted Active immunisation against influenza in adults aged ≥65 years of age for prevention of seasonal influenza. | Mar 2018 | Recommended | none received |
| quadrivalent influenza vaccine Prevention of influenza in Aboriginal and/or Torres Strait Islander people aged 5 to <15 years. This expands the existing NIP eligibility from the current age… | Nov 2018 | Recommended with restriction | no section in document |
| quadrivalent influenza vaccine (inactivated, split virion) Prevention of seasonal influenza caused by influenza virus Types A and B in adults aged 18 years and older eligible for NIP-funded influenza vaccine. | Aug 2016 | Deferred | no section in document |
| quadrivalent influenza vaccine Active immunisation for the prevention of seasonal influenza in persons aged 3 years and over, including high-risk individuals. | Mar 2015 | Recommended | none received |
Who spoke
Lung Foundation Australia · Australian Immunisation Register · Immunisation Coalition · Immunisation Foundation · Pediatric Infectious Diseases Society
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 4 of 8 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.